Telemedicine as a tool for dietary intervention in NAFLD-HIV patients during the COVID-19 lockdown: A randomized controlled trial
Authors:
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 43, 329-334
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Global burden of NAFLD and NASH: trends, predictions, risk factors and preventionNature Reviews Gastroenterology & Hepatology, 2017
- Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in patients with HIVThe Lancet Gastroenterology & Hepatology, 2017
- Detecting liver fat from viscoelasticity: How good is CAP in clinical practice? The need for universal cut-offsJournal of Hepatology, 2017
- Managing nonalcoholic fatty liver disease in patients living with HIVCurrent Opinion in Infectious Diseases, 2017
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver diseaseJournal of Hepatology, 2016
- NAFLD: A multisystem diseaseJournal of Hepatology, 2015
- The global NAFLD epidemicNature Reviews Gastroenterology & Hepatology, 2013
- A 14-Item Mediterranean Diet Assessment Tool and Obesity Indexes among High-Risk Subjects: The PREDIMED TrialPLOS ONE, 2012
- From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patientsCurrent Opinion in Infectious Diseases, 2012
- Nonalcoholic Fatty Liver Disease in HIV‐Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and PredictorsClinical Infectious Diseases, 2008